Webinar: Re-Writing the Genome

Combining Gene Editing and iPSC Technologies for Preclinical Discovery and Translational Research Watch our webinar on-demand to hear Ruby Chen-Tsai, Ph.D., CSO of Applied StemCell, discuss how her team is using genome engineering and iPSC technologies to advance disease modeling, lead compound discovery, and bioproduction. You will learn about: Using genome engineering technologies for the […]

Read More…

In vivo Phenotypic Screening: Melior Discovery

By Natalie Foote, Director of Service Provider Operations, Science Exchange | blog.scienceexchange.com Phenotypic Screening Pioneer Launches Novel Analgesia Panel In this Provider Innovation Profile, we’re proud to feature Melior Discovery, a pioneer of in vivo phenotypic screening and a leader in the area of drug repositioning. Melior’s platform evaluates compounds through up to 40 different […]

Read More…